Plasma levels of tumor necrosis factor-α, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance

Diabetes Care

Volumn 24, Issue 2, 2001, Pages 328-334

  Blüher, Matthias ^a   Kratzsch, Juergen ^b   Paschke, Ralf ^a,b  

^a Faculty of Medicine   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; FATTY ACID; GLUCOSE; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY;

EID: 0035145487     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.2.328     Document Type: Article

References (45)

1. Role of insulin resistance in human disease
2. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
3. Insulin signal transduction and the IRS proteins
4. The IRS-signalling system during insulin and cytokine action
5. Tumor necrosis factor alpha acutely inhibits insulin signalling in human adipocytes: Implication of the p 80 tumor necrosis factor receptor
6. TNF mimics the metabolic response of acute infections in healthy humans
7. Crosstalk between insulin and angiotensin II signalling systems
8. Assessment of insulin resistance in acromegaly associated with diabetes mellitus before and after transsphenoidal adenomectomy
9. Transgenic rabbits overexpressing growth hormone develop acromegaly and diabetes mellitus
10. Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans
11. Mechanisms of fatty acid-induced inhibition of glucose uptake
12. Mechanisms of fatty acid-induced insulin resistance in humans
13. Free fatty acid and insuln resistance during pregnancy
14. Effects of fat on glucose uptake and utilization in patients with noninsulin-dependent diabetes
15. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects
16. Prolonged elevation of plasma free fatty acids desensitizes the insulin response to glucose in vivo in rats
17. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes
18. Insulin resistant phenotype is associated with high serum leptin levels in offspring of patients with non-insulin-dependent diabetes mellitus
19. Increased circulating leptin concentrations in insulin-resistant first-degree relatives of patients with noninsulin-dependent diabetes mellitus: Relationship to body composition and insulin sensitivity but not to family history of non-insulin-dependent diabetes mellitus
20. Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited
21. Insulin action and secretion in healthy, glucose tolerant first degree relatives of patients with type 2 diabetes mellitus: Influence of body weight
22. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance
23. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus
24. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
25. Glucose clamp technique: A method for quantifying insulin secretion and resistance
26. Plasma leptin levels in healthy children and adolescents: Dependence on body mass index, body fat mass, pubertal stage, and testosterone
27. Measurements of insulin-like growth factor I (IGF-I) in normal adults, patients with liver cirrhosis and acromegaly: Experience with new competitive enzyme immunoassay
28. Insulin resistant subjects lack islet adaptation to short-term dexamethason-induced reduction in insulin sensitivity
29. Leptin: The tale of an obesity gene
30. Syndromes of severe insulin resistance
31. Glucose toxicity
32. Lilly Lecture 1987. The triumvirate: β-cell, muscle, liver: A collusion responsible for NIDDM
33. Tumor necrosis factor alpha induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT-4 expression without a loss of insulin-receptor-mediated transduction
34. Reduced tyrosine kinase activity of the insulin receptor in obesitydiabetes: Central role of tumor necrosis factor alpha
35. Tumor necrosis factor alpha inhibits signalling from the insulin receptor
36. An in vivo model for elucidation of the mechanism of tumor necrosis factor-α (TNFα)-induced insulin resistance: Evidence for differential regulation of insulin signalling by TNFα
37. Increased adipose tissue expression of tumor necrosis factor alpha in human obesity and insulin resistance
38. The expression of TNF alpha by human muscle: Relationship to insulin resistance
39. Effects of engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM
40. Circulating tumor necrosis factor-α concentrations in a native Canadian population with high rates of type 2 diabetes
41. Altered action of angiotensin II in patients with type 2 diabetes mellitus of recent onset
42. Low-dose angiotensin II increases glucose disposal rate during euglycemic hyperinsulinemia
43. Decreased insulin sensitivity and compensatory hyperinsulinemia after hormone treatment in children with short stature
44. Tissue availability of insulin-like growth factor I is inversely related to insulin resistance in essential hypertension: Effects of angiotensin-converting enzyme inhibition
45. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM